Jim Cramer’s ‘Mad Money’ Recap: This Stock Market Is No BargainByScott RuttFollow|08/06/15 – 08:12 PM EDTSearch Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.NEW YORK (TheStreet) — Not every falling stock is a bargain, Jim Cramer warned his Mad Money viewers Thursday. Some are falling knives that will only lead to bright red losses.Cramer explained […]
The annual pilgrimage to the MoneyShow San Francisco has been my ritual since graduate school. Experts keep my financial knowledge base refreshed. Times change and shows like this one will eventually be completely virtual. The highlights for 2015 covered the disruption of financial advising and health care. I don’t need to repeat the most important talks because those will eventually […]
7-1-15Secular Market Top – Since January 2000+53.3% Dow+171.8% Transports+94.2% Utilities+40.4% S&P 500+22.5% Nasdaq+52.2% 30yr Treasury Bond+304.6% Gold+132.3% OilFrom High to Low+304.6% Gold+171.8% Transports+132.3% Oil+94.2% Utilities+53.3% Dow Jones+52.2% 30 Year Treasury+40.4% S&P 500+22.5% NasdaqIt is easily seen that in the year 2000 the Nasdaq was horribly overvalued and gold was on the give away table, such lopsided returns 15 years later!Here […]
Stock Market Crash ChartsStock-Markets / Financial CrashJun 22, 2015 – 08:14 AM GMTBy: Toby_ConnorIf the Fed continues to intervene and prevents the correction then we will almost certainly have an 87 style crash this fall.Gary SavageThe Smart Money TrackerGary Savage authors the Smart Money Tracker and daily financial newsletter tracking the stock & commodity markets with special emphasis on the […]
These Promising Cancer Therapies Are a Biotech Stocks “Triple Play”Companies / BioTechJun 19, 2015 – 03:04 PM GMTBy: Money_MorningErnie Tremblay writes: On Jan. 7, 2015, CytRX Corp. (NASDAQ: CYTR) announced positive results from a study of its experimental brain cancer drug, aldoxorubicin, and the company’s stock immediately jumped 15.8%. Then, over the next four months, it nearly doubled.Over the months […]
Best Investor Play in the Hottest Biotech Stock Market on EarthCompanies / Tech StocksJun 17, 2015 – 08:01 AM GMTBy: Money_MorningMichael A. Robinson writes: Biotechnology is a big opportunity. And China is a big market.Combine the two and you have a big potential for investment profits.In today’s Strategic Tech Investor, I’m talking with Money Map Press Executive Editor William Patalon […]
Download Letter (PDF)June 12, 2015Crescat Capital Quarterly Investor Letter Q2 2015Performance UpdateWe are pleased to report that the Crescat Global Macro Fund was recently named one of the top-ten performing global macro hedge funds by BarclayHedge for the three years ended 3/31/2015. As shown in the table below, all three Crescat strategies performed strongly in Q1 while the S&P 500 […]
In early April I wrote a piece arguing that biotech stocks – using the iShares Nasdaq Biotech ETF (IBB) as a proxy – looked to be under distribution. At the time the IBB traded at approximately $340. My argument rested on negative divergences in the Shares Outstanding / Price action of the IBB, Block Money Flow trends, an increase in volatility, […]
Money Murder Mystery: Who Killed the Stock Market?Stock-Markets / Stock Markets 2015May 25, 2015 – 10:12 AM GMTBy: Money_MorningShah Gilani writes: Liquidity, the “life blood” that allows the world’s capital markets to function, has been murdered.Liquidity was choked violently in the bond market by the gloved hands of its erstwhile babysitter – the broker-dealers- but it bled to death in […]
When many of us think of investing, our thoughts immediately jump to the idea of picking stocks. The hope is to find the “hot tip” or get in at the “right time” in order to make a lot of money in a short period. We talk about investing as though it’s the same as stock trading when it’s not.
William Bernstein, […]
